Prevalence of celiac disease in healthy Iranian school children

Seyed Mohsen Dehghani1, Mahmood Haghighat, Arash Mobayen

  • 1Shiraz University of Medical Sciences, Gastroenterohepatology Research Center, Shiraz Transplant Research Center, Shiraz 7193711351, Iran. dehghanism@sums.ac.ir

Insights

Silent celiac disease, a hidden form of celiac disease, affects 0.6% of healthy children in Shiraz, Iran. Early diagnosis is crucial due to potential complications in these asymptomatic children.

Area of Science:

  • Pediatric Gastroenterology
  • Immunology
  • Public Health

Background:

  • Celiac disease often presents asymptomatically as silent celiac disease.
  • Silent celiac disease poses risks of complications, necessitating early detection.
  • Investigating the prevalence of silent celiac disease in pediatric populations is vital.

Purpose of the Study:

  • To determine the prevalence of silent celiac disease in healthy school-aged children in Shiraz, Iran.
  • To highlight the public health significance of undiagnosed celiac disease in children.

Main Methods:

  • A cross-sectional study was conducted involving 1500 healthy school children aged 6-12 years in Shiraz.
  • Serological testing for anti-tissue transglutaminase immunoglobulin A antibodies was performed.
  • Intestinal biopsies were obtained for positive serology cases, analyzed using modified Marsh criteria.

Main Results:

  • A 2% seropositivity rate for anti-tissue transglutaminase immunoglobulin A antibodies was observed.
  • The prevalence of biopsy-proven silent celiac disease was found to be 0.6%.
  • The mean age of participants was 9.5 years (SD 1.3).

Conclusions:

  • Silent celiac disease is prevalent in Shiraz, indicating a significant health concern.
  • The findings suggest a need for increased awareness and screening for celiac disease in children.
  • This study contributes to understanding the epidemiology of celiac disease in Southern Iran.
Abstract

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...